Scilex raises $17M in registered direct offering, plus $1M warrant exercise

Scilex Holding Co

Gross proceeds ~$17M from sale of 26.355M shares, pre-funded warrants, and 57.513M common warrants.
Combined offering price $0.59 per share/warrant unit; common warrants at $0.649/share.
Separate warrant amendment yields ~$1.041M from exercise of 1.764M shares at $0.59.
Net proceeds for working capital, R&D, commercialization, and possible debt repayment.
Common warrants exercisable in 6 months; half expire in 2.5 yrs, half in 5 yrs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.